Taisho Pharmaceutical Holdings Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TAISF research report →
Price Chart
About the company
Taisho Pharmaceutical Holdings Co. , Ltd. , headquartered in Tokyo, Japan, is a long-established global pharmaceutical company, founded in 1912.
- CEO
- Akira Uehara
- IPO
- 2023
- Employees
- 8,784
- HQ
- Tokyo, JP
Get TickerSpark's AI analysis on TAISF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $118
- P/E
- 37.03
- PEG
- -0.56
- P/S
- 2.33
- P/B
- 0.89
- EV/EBITDA
- 8.27
- Div Yield
- 0.00%
- Gross Margin
- 59.01%
- Op Margin
- 7.64%
- Net Margin
- 6.30%
- ROE
- 2.48%
- ROIC
- 1.91%
Latest fiscal year · YoY change
- Revenue
- $301.38B+12.4%
- Gross Profit
- $177.85B+8.6%
- Op Income
- $23.02B
- Net Income
- $19.00B+44.8%
- EPS
- $231.72+43.8%
- OCF Growth
- +43.7%
- FCF Growth
- -166.6%
- 52W High
- $60.00
- 52W Low
- $38.00
- 50D MA
- $46.20
- 200D MA
- $42.12
- Beta
- 0.50
- RSI (14)
- 63
- Avg Volume
- 204
No earnings-call transcripts are available for TAISF yet.
- Free Float
- 31.2%
- Shares Outstanding
- 2
- Float Shares
- 0
Our TAISF coverage
Recent articles, reports, and earnings notes.
No research on TAISF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TAISF report →